Related references
Note: Only part of the references are listed.Characterization of the Hypercitrullination Reaction in Human Neutrophils and Other Leukocytes
Yebin Zhou et al.
MEDIATORS OF INFLAMMATION (2015)
Rheumatoid factor, not antibodies against citrullinated proteins, is associated with baseline disease activity in rheumatoid arthritis clinical trials
Daniel Aletaha et al.
ARTHRITIS RESEARCH & THERAPY (2015)
The Epstein-Barr Virus Lytic Protein BZLF1 as a Candidate Target Antigen for Vaccine Development
Alex S. Hartlage et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Anti-carbamylated protein (anti-CarP) antibodies precede the onset of rheumatoid arthritis
Jing Shi et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Chelation therapy after the Trial to Assess Chelation Therapy: results of a unique trial
Maria D. Avila et al.
CURRENT OPINION IN CARDIOLOGY (2014)
A TACTful reappraisal of chelation therapy in cardiovascular disease
Mandeep S. Sidhu et al.
NATURE REVIEWS CARDIOLOGY (2014)
Chelation therapy and cardiovascular disease: Connecting scientific silos to benefit cardiac patients
Julio G. Peguero et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2014)
Features of the Synovium of Individuals at Risk of Developing Rheumatoid Arthritis
M. J. H. de Hair et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Rheumatoid Factor as a Potentiator of Anti-Citrullinated Protein Antibody-Mediated Inflammation in Rheumatoid Arthritis
Jeremy Sokolove et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Epstein-Barr Virus-Encoded RNAs: Key Molecules in Viral Pathogenesis
Dai Iwakiri
CANCERS (2014)
Serological changes in the course of traditional and biological disease modifying therapy of rheumatoid arthritis
Christoph Boehler et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Rheumatoid factor determines structural progression of rheumatoid arthritis dependent and independent of disease activity
Daniel Aletaha et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Tumor necrosis factorinhibiting therapy preferentially targets bone destruction but not synovial inflammation in a tumor necrosis factordriven model of rheumatoid arthritis
Nikolaus B. Binder et al.
ARTHRITIS AND RHEUMATISM (2013)
Effect of Disodium EDTA Chelation Regimen on Cardiovascular Events in Patients With Previous Myocardial Infarction The TACT Randomized Trial
Gervasio A. Lamas et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
EBV-encoded small RNA1 and nonresolving inflammation in rheumatoid arthritis
Wen-Chan Chiu et al.
KAOHSIUNG JOURNAL OF MEDICAL SCIENCES (2013)
Maintenance, reduction, or withdrawal of etanercept after treatment with etanercept and methotrexate in patients with moderate rheumatoid arthritis (PRESERVE): a randomised controlled trial
Josef S. Smolen et al.
LANCET (2013)
Immune-Mediated Pore-Forming Pathways Induce Cellular Hypercitrullination and Generate Citrullinated Autoantigens in Rheumatoid Arthritis
Violeta Romero et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
EDTA chelation reappraisal following new clinical trials and regular use in millions of patients: review of preliminary findings and risk/benefit assessment
Tammy Born et al.
TOXICOLOGY MECHANISMS AND METHODS (2013)
Therapeutic blockade of TNF in patients with SLE-Promising or crazy?
Martin Aringer et al.
AUTOIMMUNITY REVIEWS (2012)
Metal chelation therapy in rheumathoid arthritis: a case report Successful management of rheumathoid arthritis by metal chelation therapy
Fabrizia Bamonti et al.
BIOMETALS (2011)
Inhibiting the C5-C5a receptor axis
Trent M. Woodruff et al.
MOLECULAR IMMUNOLOGY (2011)
Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage
Jing Shi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Anticyclic citrullinated peptide autoantibodies in systemic lupus erythematosus
Usha Singh et al.
RHEUMATOLOGY INTERNATIONAL (2011)
Antibodies against cyclic citrullinated peptides in infectious diseases-a systematic review
Isabella Lima et al.
CLINICAL RHEUMATOLOGY (2010)
Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis
Natalia Wegner et al.
IMMUNOLOGICAL REVIEWS (2010)
Therapeutic potential of complement modulation
Eric Wagner et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Epstein-Barr virus in bone marrow of rheumatoid arthritis patients predicts response to rituximab treatment
Mattias Magnusson et al.
RHEUMATOLOGY (2010)
Does damage cause inflammation? Revisiting the link between joint damage and inflammation
J. S. Smolen et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Anti-Cyclic Citrullinated Peptide Antibodies From Rheumatoid Arthritis Patients Activate Complement via Both the Classical and Alternative Pathways
L. A. Trouw et al.
ARTHRITIS AND RHEUMATISM (2009)
Structure and pathogenicity of antibodies specific for citrullinated collagen type II in experimental arthritis
Huseyin Uysal et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Synovial fluid is a site of citrullination of autoantigens in inflammatory arthritis
Andrew Kinloch et al.
ARTHRITIS AND RHEUMATISM (2008)
Autoantibodies to tumor-associated antigens: reporters from the immune system
Eng M. Tan et al.
IMMUNOLOGICAL REVIEWS (2008)
FDA Report: Eculizumab (Soliris (R)) for the Treatment of Patients with Paroxysmal Nocturnal Hemoglobinuria
Andrew Dmytrijuk et al.
ONCOLOGIST (2008)
Anti-CCP2 antibodies: An overview and perspective of the diagnostic abilities of this for early rheumatoid arthritis
Walther J. van Venrooij et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2008)
Epstein-Barr virus BZLF1 gene, a switch from latency to lytic infection, is expressed as an immediate-early gene after primary infection of B lymphocytes
Wangrong Wen et al.
JOURNAL OF VIROLOGY (2007)
Rheumatoid arthritis and the complement system
Marcin Okroj et al.
ANNALS OF MEDICINE (2007)
B-1B cells: development, selection, natural autoantibody and leukemia
Richard R. Hardy
CURRENT OPINION IN IMMUNOLOGY (2006)
Immune complexes from rheumatoid arthritis synovial fluid induce Fc gamma RIIa dependent and rheumatoid factor correlated production of tumour necrosis factor-alpha by peripheral blood mononuclear cells
Linda Mathsson et al.
ARTHRITIS RESEARCH & THERAPY (2006)
Citrullination of fibronectin in rheumatoid arthritis synovial tissue
X Chang et al.
RHEUMATOLOGY (2005)
Synovial intracellular citrullinated proteins colocalizing with peptidyl arginine deiminase as pathophysiologically relevant antigenic determinants of rheumatoid arthritis-specific humoral autoimmunity
L De Rycke et al.
ARTHRITIS AND RHEUMATISM (2005)
Identification of citrullinated alpha-enolase as a candidate autoantigen in rheumatoid arthritis
A Kinloch et al.
ARTHRITIS RESEARCH & THERAPY (2005)
Specific autoantibodies precede the symptoms of rheumatoid arthritis - A study of serial measurements in blood donors
MMJ Nielen et al.
ARTHRITIS AND RHEUMATISM (2004)
Latent Epstein-Barr virus (EBV) infection and cytomegalovirus (CMV) infection in synovial tissue of autoimmune chronic arthritis determined by RNA- and DNA-in situ hybridization
Y Mehraein et al.
MODERN PATHOLOGY (2004)
Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin
ER Vossenaar et al.
ARTHRITIS RESEARCH & THERAPY (2004)
Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis
S Rantapää-Dahlqvist et al.
ARTHRITIS AND RHEUMATISM (2003)
The complement system as a therapeutic target in autoimmunity
VM Holers
CLINICAL IMMUNOLOGY (2003)
Characterization of autoreactive T cells to the autoantigens heterogeneous nuclear ribonucleoprotein A2 (RA33) and filaggrin in patients with rheumatoid arthritis
R Fritsch et al.
JOURNAL OF IMMUNOLOGY (2002)
The major synovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the α- and β-chains of fibrin
C Masson-Bessière et al.
JOURNAL OF IMMUNOLOGY (2001)
TNF-α induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand
J Lam et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Share Paper
